Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
OCUP similar filings
- 11 Mar 21 Entry into a Material Definitive Agreement
- 4 Feb 21 Entry into a Material Definitive Agreement
- 6 Jan 21 Ocuphire Corporate Presentation January 2021
- 30 Dec 20 Financial Statements and Exhibits
- 25 Nov 20 Entry into a Material Definitive Agreement
- 17 Nov 20 Departure of Directors or Certain Officers
- 6 Nov 20 Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement Form S-4 of Rexahn Pharmaceuticals, Inc. of our report dated July 1, 2020, with respect to the financial statements of Ocuphire Pharma, Inc. included in this Current Report on Form 8-K/A.
/s/ Ernst & Young LLP
Detroit, Michigan
December 30, 2020